C.A.R.E. For Women Foundation

Purdue Technology Aids in Removal of Ovarian Cancer

CARE Support — Thu, 29 Sep 2011 16:53:34 +0000

Purdue technology used in first fluorescence-guided ovarian cancer surgery

Article published September 18, 2011 by Purdue University

WEST LAFAYETTE, Ind. – The first fluorescence-guided surgery on an ovarian cancer patient was performed using a cancer cell “homing device” and imaging agent created by a Purdue University researcher.

The surgery was one of 10 performed as part of the first phase of a clinical trial to evaluate a new technology to aid surgeons in the removal of malignant tissue from ovarian cancer patients. The method illuminates cancer cells to help surgeons identify and remove smaller tumors that could otherwise be missed.

Philip Low, the Ralph C. Corely Distinguished Professor of Chemistry who invented the technology, said surgeons were able to see clusters of cancer cells as small as one-tenth of a millimeter, as opposed to the earlier average minimal cluster size of 3 millimeters in diameter based on current methods of visual and tactile detection.

“Ovarian cancer is notoriously difficult to see, and this technique allowed surgeons to spot a tumor 30 times smaller than the smallest they could detect using standard techniques,” said Low, who also is a member of the Purdue University Center for Cancer Research. “By dramatically improving the detection of the cancer – by literally lighting it up – cancer removal is dramatically improved.”

Ovarian Cancer Awarness Month

CARE Support — Tue, 06 Sep 2011 21:05:50 +0000

Ovarian Cancer is one of the most deadly of women’s cancers. Each year, approximately 21,880 women will be diagnosed with ovarian cancer. In 2010, approximately 13,850 women will die in the United States from ovarian cancer. Many women don’t seek help until the disease has begun to spread, but if detected at its earliest stage, the five-year survival rate is more than 93%. Recent research suggests that together the four symptoms of: bloating, pelvic or abdominal pain, difficulty eating or feeling full quickly and urinary urgency or frequency may be associated with ovarian cancer…Read More.

March’s Mascarade!

admin — Sun, 15 May 2011 17:00:58 +0000

The masquerade ball was a huge success!

Thank you to everyone who came and or supported the ball! I would like to give a special thanks to our sponsors Carrot Top- Barefoot Wine,Watermark, Crave America, Sheraton Safari,Hess & Hess Acounting ,Pavlik Chiropractic and Red Design and Orlando Magazine